20-54214367-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002623.4(PFDN4):āc.41A>Gā(p.Asn14Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000041 in 1,585,988 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000053 ( 0 hom., cov: 33)
Exomes š: 0.000040 ( 1 hom. )
Consequence
PFDN4
NM_002623.4 missense
NM_002623.4 missense
Scores
4
15
Clinical Significance
Conservation
PhyloP100: 6.78
Genes affected
PFDN4 (HGNC:8868): (prefoldin subunit 4) This gene encodes a member of the prefoldin beta subunit family. The encoded protein is one of six subunits of prefoldin, a molecular chaperone complex that binds and stabilizes newly synthesized polypeptides, thereby allowing them to fold correctly. The complex, consisting of two alpha and four beta subunits, forms a double beta barrel assembly with six protruding coiled-coils. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07208392).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PFDN4 | NM_002623.4 | c.41A>G | p.Asn14Ser | missense_variant | 2/4 | ENST00000371419.7 | NP_002614.2 | |
PFDN4 | XM_047440198.1 | c.287A>G | p.Asn96Ser | missense_variant | 2/4 | XP_047296154.1 | ||
PFDN4 | XM_017027879.2 | c.182A>G | p.Asn61Ser | missense_variant | 2/4 | XP_016883368.1 | ||
PFDN4 | XM_047440199.1 | c.287A>G | p.Asn96Ser | missense_variant | 2/3 | XP_047296155.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PFDN4 | ENST00000371419.7 | c.41A>G | p.Asn14Ser | missense_variant | 2/4 | 1 | NM_002623.4 | ENSP00000360473.2 |
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152240Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
8
AN:
152240
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000106 AC: 26AN: 244988Hom.: 0 AF XY: 0.0000981 AC XY: 13AN XY: 132508
GnomAD3 exomes
AF:
AC:
26
AN:
244988
Hom.:
AF XY:
AC XY:
13
AN XY:
132508
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000398 AC: 57AN: 1433748Hom.: 1 Cov.: 25 AF XY: 0.0000364 AC XY: 26AN XY: 714540
GnomAD4 exome
AF:
AC:
57
AN:
1433748
Hom.:
Cov.:
25
AF XY:
AC XY:
26
AN XY:
714540
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74382
GnomAD4 genome
AF:
AC:
8
AN:
152240
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74382
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
9
Asia WGS
AF:
AC:
1
AN:
3476
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 19, 2024 | The c.41A>G (p.N14S) alteration is located in exon 2 (coding exon 2) of the PFDN4 gene. This alteration results from a A to G substitution at nucleotide position 41, causing the asparagine (N) at amino acid position 14 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Gain of phosphorylation at N14 (P = 0.053);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at